Portfolio company
Asymmetric Suzuki Reactions
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops catalytic asymmetric cross-coupling reactions for pharmaceutical firms to create three-dimensional molecules for enhanced drug discovery and development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Chirality Biosciences
This company develops chiral separation technology to provide pharmaceutical manufacturers with purer active ingredients for safer drug production.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
CATALYA
This company develops synthetic polymer platform technology to improve the solubility, stability and delivery of biopharmaceuticals for the pharmaceutical and biotechnology industries.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
Enantios
This company develops Raman optical activity measurement instruments and provides analytical services for pharmaceutical and chemical industries to characterise complex chiral molecules and biologics.
Excelsior Sciences
This company develops a chemistry platform using modular building blocks to automate the discovery and manufacture of small molecules for pharmaceutical and materials science customers.
Hydregen
This biotechnology company develops enzyme-based biocatalysts as drop-in replacements for metal catalysts for pharmaceutical, specialty chemical and agrochemical manufacturers.
Ladder Therapeutics
The company develops synthetic ladder-shaped molecules for pharmaceutical organisations to enable the discovery and manufacture of targeted therapeutics and diagnostic tests.
